Autor/es reacciones

Esther de la Viuda

Especialista del servicio de Ginecología y Obstetricia del Hospital Universitario de Guadalajara, Profesora Asociada en Ciencias de la Salud en la Universidad de Alcalá

The study is good, the authors are well-known professionals with extensive experience. A good and extensive literature review has been done. In relation to the solidity of the data, obviously we would always like to have more clinical trials and quality studies to establish the conclusions of any work, but we have to work with the best available evidence. In this sense, a rigorous and extensive review has been carried out here, and the data presented are supported by these studies.  

The information provided is consistent with what we know and with the current recommendations of scientific societies. It adequately positions menopausal hormone therapy as the best option for vasomotor symptomatology, with its benefits and risks; it deals with another important problem of this period, vaginal health; and it raises social situations such as the effect of symptoms on working life.  

This is a review, the limitations of the WHI [Women's Health Initiative] study have been considered and the different therapies, such as androgen therapy or non-hormonal options, have also been discussed. Finally, the need for further studies is acknowledged.  

[I think that the] publication of this type of article is important to make menopause more visible, to inform that - although it is another stage of life and it is natural - many women present vasomotor symptoms or genitourinary syndrome, which affects their quality of life in an important way, and that this can be solved effectively and safely with the current available treatments, approved by the drug agencies, always individualising the woman and insisting on the recommendations on lifestyle.

EN